Company intelligence / Profile preview

implantcast

Buxtehude, Niedersachsen, Germanyimplantcast.de ↗

Ownership: Private
Employees: ~840
Development stage: Other

Overview

implantcast’s products—including the MUTARS® tumor endoprosthesis system and a broad portfolio of primary, revision, and custom orthopedic implants—are widely used in clinical practice globally. The company has developed more than 90 products since 2009 and holds market leadership in Europe for revision, tumor, and special endoprosthetics. Their systems are FDA-approved for use in the United States.

Therapeutic areas: RheumatologyOther
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Collaborations with over eighty international distribution partnersclose cooperation with leading European university hospitals for R&D

Beyond the preview

Go deeper on implantcast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on implantcast.

Explore the full profile